Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Eur J Neurol. 2019 Sep 8;27(2):235–243. doi: 10.1111/ene.14058

Table 2.

Correlations among protein levels in multiple sclerosis patients and healthy individuals.

PC PS sEPCR   PC PS sEPCR   PC PS sEPCR PC PS sEPCR
All Multiple Sclerosis patients RR- MS P- MS   Healthy Individuals
PS Rho:
P value:
0.076
0.383
  0.066
0.555
  0.147
0.303
  0.434
0.005
sEPCR Rho:
P value:
0.111
0.204
−0.011
0.905
0.134
0.236
0.101
0.377
0.048
0.741
−0.180
0.206
  −0.030
0.858
0.270
0.097
sTM Rho:
P value:
0.099
0.251
0.079
0.365
−0.213
0.014
0.092
0.410
0.042
0.710
−0.159
0.160
0.085
0.554
0.160
0.263
−0.367
0.008
  0.013
0.938
0.115
0.478
0.187
0.254
HCII Rho:
P value:
−0.271
0.001
−0.006
0.947
−0.150
0.084
−0.274
0.012
−0.034
0.762
−0.110
0.331
−0.248
0.080
0.061
0.668
−0.187
0.189
  −0.003
0.988
0.263
0.100
−0.020
0.905
PAI-1 Rho:
P value:
0.269
0.002
0.155
0.072
0.100
0.252
0.221
0.045
0.124
0.265
0.135
0.234
0.360
0.010
0.229
0.106
0.070
0.628
  0.408
0.009
0.412
0.008
−0.055
0.738
FXII Rho:
P value:
0.281
0.001
−0.010
0.908
−0.088
0.313
0.248
0.024
−0.164
0.140
−0.078
0.493
0.323
0.021
0.301
0.032
−0.122
0.395
  −0.115
0.481
−0.126
0.438
−0.028
0.864

sTM, soluble thrombomodulin; HCII, heparin cofactor II; PAI-1, plasminogen activator inhibitor-1; FXII, factor XII.

Correlation coefficients and p-values of non-parametric partial correlation with age and sex as covariates are reported. Significant associations are in bold.

Correlations both within MS patients and in HI are reported in dark gray cells, and those observed only in MS cohort or HI in light gray cells.